nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A population-based study of glutathione S-transferase M1, T1 and P1 genotypes and risk for lung cancer
|
Nazar-Stewart, Valle |
|
2003 |
40 |
3 |
p. 247-258 12 p. |
artikel |
2 |
A prospective study of the impact of weight loss and the systemic inflammatory response on quality of life in patients with inoperable non-small cell lung cancer
|
Scott, Hazel R |
|
2003 |
40 |
3 |
p. 295-299 5 p. |
artikel |
3 |
Diagnostic value of CA 549 in pleural fluid. Comparison with CEA, CA 15.3 and CA 72.4
|
Villena, Victoria |
|
2003 |
40 |
3 |
p. 289-294 6 p. |
artikel |
4 |
Diffuse alveolar damage after ZD1839 therapy in a patient with non-small cell lung cancer
|
Okamoto, Isamu |
|
2003 |
40 |
3 |
p. 339-342 4 p. |
artikel |
5 |
Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry
|
Zhukov, Tatyana A |
|
2003 |
40 |
3 |
p. 267-279 13 p. |
artikel |
6 |
Editorial Board
|
|
|
2003 |
40 |
3 |
p. IFC- 1 p. |
artikel |
7 |
Impact of treatment interruptions due to toxicity on outcome of patients with early stage (I/II) non-small-cell lung cancer (NSCLC) treated with hyperfractionated radiation therapy alone
|
Jeremic, Branislav |
|
2003 |
40 |
3 |
p. 317-323 7 p. |
artikel |
8 |
In vitro effects of combinations of cis-amminedichloro (2-methylpyridine) platinum (II) (ZD0473) with other novel anticancer drugs on the growth of SBC-3, a human small cell lung cancer cell line
|
Kanzawa, F. |
|
2003 |
40 |
3 |
p. 325-332 8 p. |
artikel |
9 |
Mutational analysis of the transforming growth factor β receptor type I gene in primary non-small cell lung cancer
|
Zhang, Hong-Tao |
|
2003 |
40 |
3 |
p. 281-287 7 p. |
artikel |
10 |
P53 (codon 72) and P21 (codon 31) polymorphisms alter in vivo mRNA expression of p21
|
Su, Li |
|
2003 |
40 |
3 |
p. 259-266 8 p. |
artikel |
11 |
Phase II study of irinotecan and carboplatin in patients with the refractory or relapsed small cell lung cancer
|
Hirose, Takashi |
|
2003 |
40 |
3 |
p. 333-338 6 p. |
artikel |
12 |
Preiii contents
|
|
|
2003 |
40 |
3 |
p. iii- 1 p. |
artikel |
13 |
Preiv contents continued
|
|
|
2003 |
40 |
3 |
p. iv- 1 p. |
artikel |
14 |
Prev calendar of events
|
|
|
2003 |
40 |
3 |
p. v- 1 p. |
artikel |
15 |
Robert J. Ginsberg, MD FRCS(C), March 30, 1940–March 1, 2003
|
Shepherd, Frances A |
|
2003 |
40 |
3 |
p. 343-344 2 p. |
artikel |
16 |
Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung
|
Lee, Sang-wook |
|
2003 |
40 |
3 |
p. 309-315 7 p. |
artikel |
17 |
Survival among Chinese women with lung cancer in Singapore: a comparison by stage, histology and smoking status
|
Tan, Y.K. |
|
2003 |
40 |
3 |
p. 237-246 10 p. |
artikel |
18 |
Treatment of relapsed small-cell lung cancer—a focus on the evolving role of topotecan
|
Lima, Caio M.Rocha |
|
2003 |
40 |
3 |
p. 229-236 8 p. |
artikel |
19 |
ZD1839, a novel, oral epidermal growth factor receptor-tyrosine kinase inhibitor, as salvage treatment in patients with advanced non-small cell lung cancer. Experience from a single center participating in a compassionate use program
|
Pallis, A.G. |
|
2003 |
40 |
3 |
p. 301-307 7 p. |
artikel |